However, despite this clinical overlap, little is known about the cross-disease molecular programs that link autoimmunity to metabolic dysfunction which refers to insulin resistance/impaired insulin signaling, accompanied by β-cell dysfunction-related dysglycemia and atherogenic dyslipidemia/metabolic-syndrome features [28]. The gene discussed is INS; the disease is Autoimmunity.